INTERNATIONAL PATENT: MORPHIC THERAPEUTIC, INC. FILES APPLICATION FOR "INHIBITING ALPHA-V BETA-8 INTEGRIN"

GENEVA, Feb. 18 -- MORPHIC THERAPEUTIC, INC. (35 Gatehouse Drive, A2Waltham, MA 02451) filed a patent application (PCT/US2025/041303) for "INHIBITING ALPHA-V BETA-8 INTEGRIN" on Aug 08, 2025. With publication no. WO/2026/036054, the details related to the patent application was published on Feb 12, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): TROAST, Dawn, M. (c/o Morphic Therapeutic, Inc.35 Gatehouse Drive, A2Waltham, MA 02451)

Abstract: Disclosed are small molecule inhibitors of AlphavBeta8 integrin, and methods of using them to treat a number of diseases and conditions.

For more info...